Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
出版年份 2018 全文链接
标题
Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
作者
关键词
-
出版物
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 113, Issue 6, Pages 883-889
出版商
Springer Nature
发表日期
2018-06-01
DOI
10.1038/s41395-018-0104-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
- (2018) Siddharth Singh et al. PLoS One
- Pre-Morbid Obesity is Associated with Increased Risk of Developing Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
- (2017) Siddharth Singh et al. GASTROENTEROLOGY
- The underlying inflammatory chronic disease influences infliximab pharmacokinetics
- (2016) Christophe Passot et al. mAbs
- Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
- (2016) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- The Yale Open Data Access (YODA) Project — A Mechanism for Data Sharing
- (2016) Harlan M. Krumholz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries
- (2016) Pil Højgaard et al. RHEUMATOLOGY
- Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease
- (2015) Avegail Flores et al. DIGESTIVE DISEASES AND SCIENCES
- Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease
- (2015) Jennifer L. Seminerio et al. INFLAMMATORY BOWEL DISEASES
- Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients
- (2015) Florenzo Iannone et al. JOINT BONE SPINE
- Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
- (2015) Janet R. Wade et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?
- (2013) Mahesh Bhalme et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Body mass index influences the response to infliximab in ankylosing spondylitis
- (2012) Sébastien Ottaviani et al. ARTHRITIS RESEARCH & THERAPY
- Appraisal of the Pediatric Crohn's Disease Activity Index on Four Prospectively Collected Datasets: Recommended Cutoff Values and Clinimetric Properties
- (2010) Dan Turner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Body mass index and clinical response to infliximab in rheumatoid arthritis
- (2010) Ruth Klaasen et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started